Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1988-07-15
1993-07-13
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Lymphokine
424 88, 437 7, 437 89, 5303875, 5303882, 514843, A61K 3900, A61K 3514, H01L 4900, H01L 2120
Patent
active
052271609
ABSTRACT:
Monoclonal antibody NUH2 produced by a hybridoma having ATCC deposit no. HB 9762. An isolated antigen capable of specifically binding to anti-human sperm antibodies including NUH2 and comprising at least an epitope having a sialyl I structure, and any analogues derived from said antigen. Methods of using the monoclonal antibody and antigen for contraception and treating infertility in human females.
REFERENCES:
patent: 4795634 (1989-01-01), Grimes et al.
patent: 5051251 (1991-09-01), Morita et al.
patent: 5051425 (1991-09-01), Nakai
patent: 5051445 (1991-09-01), Louis et al.
Pharmaceutical Technology, Parrott, Burgess Publ. Co., MN, 1970.
Selected Methods in Cellular Immunology, Mishell & Shiigi, W. H. Freeman, S. F., 1980.
Essential Immunology, Roitt, Blackwell, Oxford, 1971.
Hakomori Sen-itiroh
Isojima Shinzo
Kaizu Tokio
Levery Steven B.
Mandel-Clausen Ulla
Criares T. J.
Hyogo Medical College
The Biomembrane Institute
Waddell Frederick E.
LandOfFree
Monoclonal antibody NUH2 capable of inactivating motility of hum does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibody NUH2 capable of inactivating motility of hum, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody NUH2 capable of inactivating motility of hum will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2310314